185 related articles for article (PubMed ID: 8621911)
1. Peptide-dependent expression of HLA-B7 on antigen processing-deficient T2 cells.
Smith KD; Lutz CT
J Immunol; 1996 May; 156(10):3755-64. PubMed ID: 8621911
[TBL] [Abstract][Full Text] [Related]
2. TAP-independent MHC class I peptide antigen presentation to alloreactive CTL is enhanced by target cell incubation at subphysiologic temperatures.
Shi Y; Smith KD; Lutz CT
J Immunol; 1998 May; 160(9):4305-12. PubMed ID: 9574533
[TBL] [Abstract][Full Text] [Related]
3. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
Vigna JL; Smith KD; Lutz CT
J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
[TBL] [Abstract][Full Text] [Related]
4. Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry.
Weinzierl AO; Rudolf D; Hillen N; Tenzer S; van Endert P; Schild H; Rammensee HG; Stevanović S
Eur J Immunol; 2008 Jun; 38(6):1503-10. PubMed ID: 18446792
[TBL] [Abstract][Full Text] [Related]
5. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
6. Point mutations in the alpha 2 domain of HLA-A2.1 define a functionally relevant interaction with TAP.
Lewis JW; Neisig A; Neefjes J; Elliott T
Curr Biol; 1996 Jul; 6(7):873-83. PubMed ID: 8805302
[TBL] [Abstract][Full Text] [Related]
7. Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules.
Daniel S; Brusic V; Caillat-Zucman S; Petrovsky N; Harrison L; Riganelli D; Sinigaglia F; Gallazzi F; Hammer J; van Endert PM
J Immunol; 1998 Jul; 161(2):617-24. PubMed ID: 9670935
[TBL] [Abstract][Full Text] [Related]
8. Alloreactive cytotoxic T lymphocytes focus on specific major histocompatibility complex-bound peptides.
Smith KD; Huczko E; Engelhard VH; Li YY; Lutz CT
Transplantation; 1997 Jul; 64(2):351-9. PubMed ID: 9256200
[TBL] [Abstract][Full Text] [Related]
9. An improved method for the detection of peptide-induced upregulation of HLA-A2 molecules on TAP-deficient T2 cells.
Regner M; Claësson MH; Bregenholt S; Röpke M
Exp Clin Immunogenet; 1996; 13(1):30-5. PubMed ID: 8854086
[TBL] [Abstract][Full Text] [Related]
10. Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: intracellular loading and kinetics of presentation.
Luft T; Rizkalla M; Tai TY; Chen Q; MacFarlan RI; Davis ID; Maraskovsky E; Cebon J
J Immunol; 2001 Sep; 167(5):2529-37. PubMed ID: 11509592
[TBL] [Abstract][Full Text] [Related]
11. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class I expression in type I diabetic cells.
Wang F; Li X; Annis B; Faustman DL
Hum Gene Ther; 1995 Aug; 6(8):1005-17. PubMed ID: 7578413
[TBL] [Abstract][Full Text] [Related]
12. HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1.
Stuber G; Dillner J; Modrow S; Wolf H; Székely L; Klein G; Klein E
Int Immunol; 1995 Apr; 7(4):653-63. PubMed ID: 7547693
[TBL] [Abstract][Full Text] [Related]
13. Asymptomatic deficiency in the peptide transporter associated to antigen processing (TAP).
de la Salle H; Saulquin X; Mansour I; Klayme S; Fricker D; Zimmer J; Cazenave JP; Hanau D; Bonneville M; Houssaint E; Lefranc G; Naman R
Clin Exp Immunol; 2002 Jun; 128(3):525-31. PubMed ID: 12067308
[TBL] [Abstract][Full Text] [Related]
14. Major histocompatibility complex class I molecules interact with both subunits of the transporter associated with antigen processing, TAP1 and TAP2.
Powis SJ
Eur J Immunol; 1997 Oct; 27(10):2744-7. PubMed ID: 9368636
[TBL] [Abstract][Full Text] [Related]
15. Probing HLA-B7 conformational shifts induced by peptide-binding groove mutations and bound peptide with anti-HLA monoclonal antibodies.
Smith KD; Mace BE; Valenzuela A; Vigna JL; McCutcheon JA; Barbosa JA; Huczko E; Engelhard VH; Lutz CT
J Immunol; 1996 Sep; 157(6):2470-8. PubMed ID: 8805647
[TBL] [Abstract][Full Text] [Related]
16. Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells.
Kobayashi H; Kimura S; Aoki N; Sato K; Celis E; Katagiri M
Immunogenetics; 2001 Oct; 53(8):626-33. PubMed ID: 11797095
[TBL] [Abstract][Full Text] [Related]
17. Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope.
Raafat N; Sadowski-Cron C; Mengus C; Heberer M; Spagnoli GC; Zajac P
Int J Cancer; 2012 Sep; 131(5):E659-69. PubMed ID: 22116674
[TBL] [Abstract][Full Text] [Related]
18. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
Bai A; Forman J
J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
[TBL] [Abstract][Full Text] [Related]
19. Promiscuous binding of invariant chain-derived CLIP peptide to distinct HLA-I molecules revealed in leukemic cells.
van Luijn MM; van de Loosdrecht AA; Lampen MH; van Veelen PA; Zevenbergen A; Kester MG; de Ru AH; Ossenkoppele GJ; van Hall T; van Ham SM
PLoS One; 2012; 7(4):e34649. PubMed ID: 22563374
[TBL] [Abstract][Full Text] [Related]
20. Interactions formed by individually expressed TAP1 and TAP2 polypeptide subunits.
Antoniou AN; Ford S; Pilley ES; Blake N; Powis SJ
Immunology; 2002 Jun; 106(2):182-9. PubMed ID: 12047747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
